Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jenny Persson

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Cancers|May 4, 2026
Modifying Epigenetic Landscapes to Restore Immune Therapeutic Responses in Triple Negative Breast CancerNabeelah Almalki, Mercedes Vázquez-Cantú, Riba Thomas, et al.
The Journal of Clinical Endocrinology and Metabolism|December 20, 2018
Water Supplementation Reduces Copeptin and Plasma Glucose in Adults With High Copeptin: The H2O Metabolism Pilot StudySofia Enhörning, Louise Brunkwall, Irina Tasevska, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|August 21, 2008
Recurrent symptoms after fundoplication with a negative pH study--recurrent reflux or functional heartburn?Sarah K Thompson, Wang Cai, Glyn G Jamieson, et al.
Infection and Immunity|February 2, 2011
Differential requirements for NAIP5 in activation of the NLRC4 inflammasomeKarla L Lightfield, Jenny Persson, Norver J Trinidad, et al.
Nature Immunology|August 30, 2008
Critical function for Naip5 in inflammasome activation by a conserved carboxy-terminal domain of flagellinKarla L Lightfield, Jenny Persson, Sky W Brubaker, et al.
Gut|July 7, 2012
Sensory neuro-immune interactions differ between irritable bowel syndrome subtypesPatrick A Hughes, Andrea M Harrington, Joel Castro, et al.
Infectious Diseases (London, England)|September 29, 2015
Six-week follow-up after HIV-1 exposure: a position statement from the Public Health Agency of Sweden and the Swedish Reference Group for Antiviral TherapyHans Gaines, Jan Albert, Maria Axelsson, et al.
Molecular Cancer|October 15, 2025
Thyroid hormone receptor beta signaling is a targetable driver of prostate cancer growthAleksandra Fesiuk, Daniel Pölöske, Elvin D de Araujo, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Cancers|May 4, 2026
Modifying Epigenetic Landscapes to Restore Immune Therapeutic Responses in Triple Negative Breast CancerNabeelah Almalki, Mercedes Vázquez-Cantú, Riba Thomas, et al.
The Journal of Clinical Endocrinology and Metabolism|December 20, 2018
Water Supplementation Reduces Copeptin and Plasma Glucose in Adults With High Copeptin: The H2O Metabolism Pilot StudySofia Enhörning, Louise Brunkwall, Irina Tasevska, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|August 21, 2008
Recurrent symptoms after fundoplication with a negative pH study--recurrent reflux or functional heartburn?Sarah K Thompson, Wang Cai, Glyn G Jamieson, et al.
Infection and Immunity|February 2, 2011
Differential requirements for NAIP5 in activation of the NLRC4 inflammasomeKarla L Lightfield, Jenny Persson, Norver J Trinidad, et al.
Nature Immunology|August 30, 2008
Critical function for Naip5 in inflammasome activation by a conserved carboxy-terminal domain of flagellinKarla L Lightfield, Jenny Persson, Sky W Brubaker, et al.
Gut|July 7, 2012
Sensory neuro-immune interactions differ between irritable bowel syndrome subtypesPatrick A Hughes, Andrea M Harrington, Joel Castro, et al.
Infectious Diseases (London, England)|September 29, 2015
Six-week follow-up after HIV-1 exposure: a position statement from the Public Health Agency of Sweden and the Swedish Reference Group for Antiviral TherapyHans Gaines, Jan Albert, Maria Axelsson, et al.
Molecular Cancer|October 15, 2025
Thyroid hormone receptor beta signaling is a targetable driver of prostate cancer growthAleksandra Fesiuk, Daniel Pölöske, Elvin D de Araujo, et al.
Pageof 3